GT Biopharma (GTBP) has filed a Request for Withdrawal with the U.S. Securities and Exchange Commission with respect to the withdrawal of the Company’s Registration Statement on Form S-1 that it ...

--IMUNON, Inc., a clinical-stage company in Phase 3 development with its DNA-mediated immunotherapy, today announced that it has filed a request for withdrawal with the Securities and Exchange ...

LIXTE Biotechnology Holdings, Inc. is a clinical-stage pharmaceutical company focused on new targets for cancer drug development and developing and commercializing cancer therapies. LIXTE has ...

You should carefully review our Annual Report on Form 10-K for the year ended December 31, 2024, as amended, and the other reports we have filed or will file with the SEC for a more complete ...

AUSTIN, TX/ ACCESS Newswire/ February 13, 2025/ Aspira Women's Health Inc., a bio-analytical based women's health company focused on the development of gynecologic disease diagnostic tools, today ...